Table 4.
Secondary analysis: main results.
| Delirium (n=271) | Nondelirium (n=201) | p value | |
|---|---|---|---|
| Use of midazolam (days#) | 2 (1–3) | 2 (1–3) | 0.56 |
| Use of antipsychotics∗ | |||
| Haloperidol (%) | 81 | 8 | <0.001 |
| Quetiapine (%) | 31 | 3 | <0.001 |
| Use of sedatives∗ (%) | |||
| Clorazepate | 8 | 1 | <0.001 |
| Propofol | 63 | 0 | <0.001 |
| Others | 41 | 4 | <0.001 |
| LOS ICU (days) | 8 (6–15) | 5 (4–7) | <0.001 |
| LOS hospital (days) | 20 (13–34) | 13 (9–19) | <0.001 |
| Mechanical ventilation (hours) | 78 (23–186) | 23 (4–64) | <0.001 |
| ICU mortality (%) | 9.9 | 9.9 | 1 |
| Hospital mortality (%) | 13.6 | 11.4 | 0.58 |
Data are presented as median (IQR). CAM-ICU: Confusion Assessment Method in the Intensive Care Unit, LOS: length of stay, ICU: intensive care unit. #For the initial sedation ∗To treat delirium.